查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594388

近視和老花眼治療市場：按治療方法和適應症分類 - 2025-2030年全球預測

Myopia & Presbyopia Treatment Market by Treatment (Contact Lenses, Medication, Prescription Lenses), Indication (Myopia, Presbyopia) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年近視和老花眼治療市值為194.7億美元，預計到2024年將達到209億美元，複合年成長率為7.84%，到2030年將達到330.4億美元。

近視和老花眼治療市場包括各種旨在矯正這些常見視力障礙的產品和服務。近視（近視）和老花（與老齡化相關的遠視）需要不同但有時重疊的治療方法，包括框架眼鏡、隱形眼鏡、手術解決方案和新的藥物方法。這些治療是必要的，因為由於人口老化和年輕人螢幕時間增加等因素，視力障礙的盛行率正在增加。應用範圍包括矯正眼鏡、屈光矯正手術以及角膜塑形鏡片和阿托品眼藥水等創新介入措施。最終使用領域包括驗光診所、醫院、專業眼科護理中心和線上零售平台。

主要市場統計
基準年[2023] 194.7億美元
預測年份 [2024] 209億美元
預測年份 [2030] 330.4億美元
複合年成長率（%） 7.84%

關鍵的成長要素包括晶狀體材料和手術技術的技術進步、眼睛健康意識的提高以及新興市場治療的可負擔性。開發非侵入性治療和數位解決方案的機會比比皆是，例如虛擬試戴技術和遠端醫療服務。公司應該專注於利用人工智慧驅動的診斷和客製化解決方案的個人化治療計劃。與科技公司的合作還可以推動旨在減輕數位眼睛疲勞的智慧眼鏡產品的成長。

然而，市場成長面臨限制，例如先進手術選擇的高成本、監管挑戰以及低成本替代方案的擴散。競爭壓力和治療複雜性也帶來了挑戰。創新的關鍵領域包括開發永續、生物分解性的鏡片材料、先進的抗反射膜以及進一步探索藥物治療。預防兒童近視以及生活方式因素與老花眼進展之間關係的研究可能會為產品開發開闢新途徑。

總體而言，該市場的特點是技術快速發展和競爭格局。保持領先需要持續創新、策略夥伴關係以及對不斷變化的消費者趨勢和法規的回應。公司應專注於改善患者體驗、負擔能力和環境永續性，以推動成長並滿足全球市場不斷變化的需求。

市場動態：揭示快速發展的近視和老花眼治療市場的主要市場洞察

近視和老花眼治療市場正因供需的動態互動而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 視力障礙盛行率增加
    • 老年人口增加
    • 老花眼矯正的微創替代方案
  • 市場限制因素
    • 缺乏早期診斷和產品召回
  • 市場機會
    • 市場合併活性化
    • 引進先進鏡片（例如植入隱形眼鏡）的新發展
  • 市場挑戰
    • 治療高成本

波特五力：駕馭近視與老花眼治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對近視和老花眼治療市場的影響

外部宏觀環境因素在塑造近視和老花眼治療市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解近視和老花眼治療市場的競爭狀況

對近視和老花眼治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV定位矩陣近視老花治療市場廠商績效評估

FPNV定位矩陣是評估近視/老花治療市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製近視和老花眼治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對近視和老花眼治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 視力障礙增加
      • 人口老化加劇
      • 老花眼矯正的微創替代方案
    • 抑制因素
      • 缺乏早期診斷和產品召回
    • 機會
      • 市場整合活動增加
      • 引進先進鏡片（例如植入隱形眼鏡）的新發展
    • 任務
      • 治療費用高
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 近視與老花眼治療市場（依治療分類）

  • 隱形眼鏡
  • 藥物治療
  • 處方鏡片
  • 外科手術

第7章依適應症分類的近視與老花眼治療市場

  • 近視
  • 老花眼

第8章北美和南美近視和老花眼治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區近視及老花眼治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲近視和老花眼治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • ABB Optical Group
  • AbbVie Inc.
  • Accu-Lens Inc.
  • Alcon Vision LLC
  • Arctic Vision
  • Bausch & Lomb Incorporated by Bausch Health Companies Inc.
  • Carl Zeiss AG
  • CooperVision, Inc.
  • Essilor Group
  • Euclid Systems Corporation
  • Eyenovia, Inc.
  • Haag-Streit Group
  • Johnson & Johnson Vision
  • Menicon Co., Ltd.
  • Nidek Co. Ltd.
  • Topcon Corporation
  • Tylock-George Eye Care & Laser Center
  • Ziemer Ophthalmic Systems AG
Product Code: MRR-034230D3E2DD

The Myopia & Presbyopia Treatment Market was valued at USD 19.47 billion in 2023, expected to reach USD 20.90 billion in 2024, and is projected to grow at a CAGR of 7.84%, to USD 33.04 billion by 2030.

The market for myopia and presbyopia treatments encompasses a range of products and services aimed at correcting these common vision impairments. Myopia (nearsightedness) and presbyopia (age-related farsightedness) require different but sometimes overlapping treatments, including glasses, contact lenses, surgical solutions, and emerging pharmacological approaches. The necessity of these treatments is driven by the increasing prevalence of visual impairments due to factors like aging populations and high screen time among younger demographics. Applications span corrective eyewear, refractive surgery, and innovative interventions such as ortho-k lenses and atropine drops. End-use sectors include optometry clinics, hospitals, specialized eye care centers, and online retail platforms.

KEY MARKET STATISTICS
Base Year [2023] USD 19.47 billion
Estimated Year [2024] USD 20.90 billion
Forecast Year [2030] USD 33.04 billion
CAGR (%) 7.84%

Key growth factors include technological advancements in lens materials and surgical techniques, heightened awareness of eye health, and increased affordability of treatments across emerging markets. Opportunities are abundant in the development of non-invasive treatments and digital solutions, like virtual try-on technologies and telehealth services. Companies should focus on personalized treatment plans leveraging AI for diagnosis and tailored solutions. Collaborations with tech firms could also drive growth in smart eyewear designed to reduce digital eye strain.

However, market growth faces limitations such as high costs of advanced surgical options, regulatory challenges, and the widespread availability of low-cost alternatives. Competitive pressures and the complexity of certain treatments also pose challenges. Key areas for innovation include the development of sustainable and biodegradable lens materials, advanced anti-reflective coatings, and further exploration of pharmacological treatments. Research into myopia prevention in children and the link between lifestyle factors and presbyopia progression could unlock new avenues for product development.

Overall, the market is characterized by rapid technological evolution and a competitive landscape. Staying ahead requires continuous innovation, strategic partnerships, and responsiveness to consumer trends and regulatory shifts. Businesses should focus on enhancing patient experiences, affordability, and environmental sustainability to drive growth and meet the evolving demands of a global market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Myopia & Presbyopia Treatment Market

The Myopia & Presbyopia Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Prevalence of Vision Impairment
    • Rising Geriatric Population
    • Minimally Invasive Alternative for Presbyopia Correction
  • Market Restraints
    • Lack of Early Diagnosis and Product Recalls
  • Market Opportunities
    • Increasing Market Amalgamation Activity
    • Emerging Developments with Introduction of Advanced Lenses such as Implantable Contact Lenses
  • Market Challenges
    • High Cost Associated with the Treatment

Porter's Five Forces: A Strategic Tool for Navigating the Myopia & Presbyopia Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Myopia & Presbyopia Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Myopia & Presbyopia Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Myopia & Presbyopia Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Myopia & Presbyopia Treatment Market

A detailed market share analysis in the Myopia & Presbyopia Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Myopia & Presbyopia Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Myopia & Presbyopia Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Myopia & Presbyopia Treatment Market

A strategic analysis of the Myopia & Presbyopia Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Myopia & Presbyopia Treatment Market, highlighting leading vendors and their innovative profiles. These include ABB Optical Group, AbbVie Inc., Accu-Lens Inc., Alcon Vision LLC, Arctic Vision, Bausch & Lomb Incorporated by Bausch Health Companies Inc., Carl Zeiss AG, CooperVision, Inc., Essilor Group, Euclid Systems Corporation, Eyenovia, Inc., Haag-Streit Group, Johnson & Johnson Vision, Menicon Co., Ltd., Nidek Co. Ltd., Topcon Corporation, Tylock-George Eye Care & Laser Center, and Ziemer Ophthalmic Systems AG.

Market Segmentation & Coverage

This research report categorizes the Myopia & Presbyopia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment, market is studied across Contact Lenses, Medication, Prescription Lenses, and Surgery.
  • Based on Indication, market is studied across Myopia and Presbyopia.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Vision Impairment
      • 5.1.1.2. Rising Geriatric Population
      • 5.1.1.3. Minimally Invasive Alternative for Presbyopia Correction
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of Early Diagnosis and Product Recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing Market Amalgamation Activity
      • 5.1.3.2. Emerging Developments with Introduction of Advanced Lenses such as Implantable Contact Lenses
    • 5.1.4. Challenges
      • 5.1.4.1. High Cost Associated with the Treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Myopia & Presbyopia Treatment Market, by Treatment

  • 6.1. Introduction
  • 6.2. Contact Lenses
  • 6.3. Medication
  • 6.4. Prescription Lenses
  • 6.5. Surgery

7. Myopia & Presbyopia Treatment Market, by Indication

  • 7.1. Introduction
  • 7.2. Myopia
  • 7.3. Presbyopia

8. Americas Myopia & Presbyopia Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Myopia & Presbyopia Treatment Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Myopia & Presbyopia Treatment Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ABB Optical Group
  • 2. AbbVie Inc.
  • 3. Accu-Lens Inc.
  • 4. Alcon Vision LLC
  • 5. Arctic Vision
  • 6. Bausch & Lomb Incorporated by Bausch Health Companies Inc.
  • 7. Carl Zeiss AG
  • 8. CooperVision, Inc.
  • 9. Essilor Group
  • 10. Euclid Systems Corporation
  • 11. Eyenovia, Inc.
  • 12. Haag-Streit Group
  • 13. Johnson & Johnson Vision
  • 14. Menicon Co., Ltd.
  • 15. Nidek Co. Ltd.
  • 16. Topcon Corporation
  • 17. Tylock-George Eye Care & Laser Center
  • 18. Ziemer Ophthalmic Systems AG

LIST OF FIGURES

  • FIGURE 1. MYOPIA & PRESBYOPIA TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. MYOPIA & PRESBYOPIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. MYOPIA & PRESBYOPIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MYOPIA & PRESBYOPIA TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MYOPIA & PRESBYOPIA TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CONTACT LENSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY PRESCRIPTION LENSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MYOPIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY PRESBYOPIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. MYOPIA & PRESBYOPIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. MYOPIA & PRESBYOPIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023